Longitudinal associations between use of antihypertensive, antidiabetic, and lipid-lowering medications and biological aging
暂无分享,去创建一个
L. Ferrucci | A. Sjölander | S. Hägg | N. Pedersen | K. Johnell | C. Reynolds | M. Thambisetty | D. Finkel | J. Jylhävä | Yunzhang Wang | Xia Li | Bowen Tang
[1] O. Hanon,et al. Blood pressure, antihypertensive drugs, and incident frailty: The Multidomain Alzheimer Preventive Trial (MAPT). , 2022, Maturitas.
[2] A. Makarov,et al. Targeting aging mechanisms: pharmacological perspectives , 2022, Trends in Endocrinology & Metabolism.
[3] M. Levine,et al. A computational solution for bolstering reliability of epigenetic clocks: implications for clinical trials and longitudinal tracking , 2021, Nature Aging.
[4] L. Berk,et al. Predictors of Biological Age: The Implications for Wellness and Aging Research , 2021, Gerontology & geriatric medicine.
[5] D. Palli,et al. DNA methylation‐based biomarkers of aging were slowed down in a two‐year diet and physical activity intervention trial: the DAMA study , 2021, Aging cell.
[6] S. Kardia,et al. Accelerated DNA methylation age and medication use among African Americans , 2021, Aging.
[7] Chen Du,et al. A systematic review and meta-analysis of early diagnosis and treatment of hypertensive stroke under calcium channel blockers. , 2021, Annals of palliative medicine.
[8] M. Szyf,et al. Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial , 2021, Aging.
[9] Chien-Yeh Hsu,et al. Calcium Channel blockers are associated with reduced risk of Parkinson's disease in patients with hypertension: A population-based retrospective cohort study , 2021, Journal of the Neurological Sciences.
[10] E. Larson,et al. Antihypertensive Medication Classes and the Risk of Dementia: A Systematic Review and Network Meta-analysis. , 2021, Journal of the American Medical Directors Association.
[11] Yoichiro Tanaka,et al. Metolazone upregulates mitochondrial chaperones and extends lifespan in Caenorhabditis elegans , 2020, Biogerontology.
[12] Seul Gi Kim,et al. Nifedipine-induced AMPK activation alleviates senescence by increasing autophagy and suppressing of Ca2+ levels in vascular smooth muscle cells , 2020, Mechanisms of Ageing and Development.
[13] D. Belsky,et al. Patterns of Reliability: Assessing the Reproducibility and Integrity of DNA Methylation Measurement , 2020, Patterns.
[14] Jian Li,et al. Verapamil extends lifespan in Caenorhabditis elegans by inhibiting calcineurin activity and promoting autophagy , 2020, Aging.
[15] S. Hägg,et al. Drivers of Frailty from Adulthood into Old Age: Results from a 27-Year Longitudinal Population-Based Study in Sweden , 2019, The journals of gerontology. Series A, Biological sciences and medical sciences.
[16] S. Horvath,et al. Reversal of epigenetic aging and immunosenescent trends in humans , 2019, Aging cell.
[17] N. Pedersen,et al. Functional Aging Index Complements Frailty in Prediction of Entry into Care and Mortality. , 2019, The journals of gerontology. Series A, Biological sciences and medical sciences.
[18] E. Colicino,et al. Accelerated DNA methylation age and the use of antihypertensive medication among older adults , 2018, Aging.
[19] D. Belsky. LIFE-COURSE LONGITUDINAL STUDIES ARE NEEDED TO ADVANCE INTEGRATION OF GENOMICS AND SOCIAL EPIDEMIOLOGY. , 2018, American journal of epidemiology.
[20] D. Bernard,et al. Calcium signaling and cellular senescence. , 2017, Cell calcium.
[21] J. Bakdash,et al. Repeated Measures Correlation , 2017, Front. Psychol..
[22] Nancy L. Pedersen,et al. Biological Age Predictors , 2017, EBioMedicine.
[23] Michael Petrascheck,et al. The DrugAge database of aging‐related drugs , 2017, Aging cell.
[24] James M. Flegal,et al. Combined statin and angiotensin-converting enzyme (ACE) inhibitor treatment increases the lifespan of long-lived F1 male mice , 2016, AGE.
[25] S. Hägg,et al. Longitudinal decline of leukocyte telomere length in old age and the association with sex and genetic risk , 2016, Aging.
[26] Hsing-Yi Chang,et al. Protective Effect of Calcium Channel Blockers Against Frailty in Older Adults with Hypertension , 2016, Journal of the American Geriatrics Society.
[27] A. Sjölander,et al. Doubly Robust Estimation with the R Package drgee , 2015 .
[28] Polina Mamoshina,et al. Geroprotectors.org: a new, structured and curated database of current therapeutic interventions in aging and age-related disease , 2015, Aging.
[29] Ming Wang,et al. Generalized Estimating Equations in Longitudinal Data Analysis: A Review and Recent Developments , 2014 .
[30] E. Schadt,et al. Geroscience: Linking Aging to Chronic Disease , 2014, Cell.
[31] B. Braeckman,et al. Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2 , 2014, Proceedings of the National Academy of Sciences.
[32] Daniel R. Jeske,et al. β1-Adrenergic receptor blockade extends the life span of Drosophila and long-lived mice , 2013, AGE.
[33] Michael L. Johnson,et al. Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus , 2012, Alzheimer's & Dementia.
[34] L. Fugger,et al. Use of calcium channel blockers and Parkinson's disease. , 2012, American journal of epidemiology.
[35] P. Allison. Fixed Effects Regression Models , 2009 .
[36] Anders Sundström,et al. The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months , 2007, Pharmacoepidemiology and drug safety.
[37] D. James Surmeier,et al. ‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease , 2007, Nature.
[38] N. Pedersen,et al. Quantitative genetic analysis of latent growth curve models of cognitive abilities in adulthood. , 2005, Developmental psychology.
[39] Nancy L. Pedersen,et al. Processing Speed and Longitudinal Trajectories of Change for Cognitive Abilities: The Swedish Adoption/Twin Study of Aging , 2004 .